Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/21/2026, 9:20:45 AM
    Content snapshot
    {
      "session_id": "sess_SDA-2026-04-08-gap-pubmed-20260406-062212-6777e5dd_task_9aae8fc5",
      "round_number": 2,
      "agent_persona": "persona-skeptic",
      "agent_backend": "scidex.core.llm.complete",
      "action": "critique",
      "content": "# Critical Evaluation of ALS Neuron-Specific Autophagy Hypotheses\n\n---\n\n## Hypothesis 1: Axonal Transport Defect (C9orf72/RAB7/Dynein)\n\n### Weak Links\n- **Causal direction ambiguous**: Axonal autophagosome accumulation in C9orf72 patient iPSCs could reflect *increased distal initiation* rather than impaired retrograde transport\n- **Haploinsufficiency assumption contested**: Evidence increasingly supports toxic gain-of-function (RNA foci, dipeptidyl repeat proteins) as primary mechanism; haploinsufficiency may be secondary\n- **Mechanistic leap**: Direct C9orf72→dynein-dynactin complex formation is not biochemically demonstrated; cited RAB7L1 (not RAB7A) interactions may not generalize\n- **Motor neuron specificity unsupported**: C9orf72 is ubiquitously expressed; mechanism does not explain selective vulnerability\n\n### Counter-Evidence\n- C9orf72 iPSC models show heterogeneous results—some report normal or hyperactive autophagic flux\n- Dynein dysfunction alone does not produce ALS-like phenotypes in all contexts\n- Alternative C9orf72 functions (stress granules, endosomal trafficking) could explain accumulation independently of axonal transport\n\n### Falsifying Experiments\n1. Pharmacologically inhibit dynein in control neurons; if this phenocopies C9orf72-specific transport defects, the mechanism gains support\n2. Test whether V-SNARE–mediated autophagosome-lysosome fusion is intact in distal vs. proximal compartments—fusion defect would argue against pure transport model\n3. Use microtubule stabilizing agents (paclitaxel) to rescue transport; specific rescue supports mechanism\n4. Quantify anterograde transport rates, not just retrograde\n\n**Revised Confidence: 0.62**\n\n---\n\n## Hypothesis 2: OPTN/TBK1 Mitophagy Axis\n\n### Weak Links\n- **\"PINK1-Parkin-independent\" overstatement**: Literature shows substantial crosstalk; PINK1/Parkin pathway can partially compensate\n- **Neuronal specificity claim unsubstantiated**: Cited evidence (PMID: 31359046) does not definitively establish that motor neurons have \"limited mitophagy redundancy\" compared to other cell types\n- **S177 phosphorylation**: Whether this specific site is the critical ALS-relevant phospho-regulatory site lacks mutational hotspots analysis\n- **Explains mutation ≠ explains vulnerability**: Even if OPTN/TBK1 are the critical mitophagy receptors, this does not mechanistically explain *why motor neurons* are selectively vulnerable\n\n### Counter-Evidence\n- TBK1 knockout mice do not fully recapitulate ALS phenotype\n- Some ALS-linked OPTN mutations are hypomorphic but retain function—paradoxical if pathway is singularly critical\n- Cortical neurons and other high-energy-demand neurons also depend on this pathway yet are less affected in ALS\n- Mitophagy can proceed via multiple receptors (NDP52, T6BP) with redundancy\n\n### Falsifying Experiments\n1. Conditional knockout of *both* OPTN and Parkin in motor neurons—if phenotype does not worsen, primary mechanism is questionable\n2. Test whether mitochondrial dysfunction in OPTN-mutant motor neurons precedes behavioral phenotype\n3. Compare mitophagy rates in motor neurons vs. proprioceptive sensory neurons (also high metabolic demand but spared early in ALS)\n4. Express ALS-mutant OPTN specifically in glia; if non-cell-autonomous effects occur, neuronal specificity is incomplete\n\n**Revised Confidence: 0.58**\n\n---\n\n## Hypothesis 3: TDP-43/SNAP29/STX17 SNARE Complex\n\n### Weak Links\n- **Temporal causality uncertain**: TDP-43 pathology is present in >95% of ALS cases *but may be downstream* of earlier autophagic defects rather than a primary cause\n- **SNAP29 clinical phenotype mismatch**: SNAP29 mutations cause **Seckel syndrome** (developmental), not ALS; this argues against a direct ALS-specific mechanism\n- **Mechanistic direction**: TDP-43 aggregates may sequester SNAP29 as a *consequence* of failed clearance, not the primary block\n- **Evidence for TDP-43 directly regulating SNAP29 splicing is indirect** (PMID: 31138729 shows splicing changes, not necessarily functional protein sequestration)\n\n### Counter-Evidence\n- Autophagy defects are observed in ALS animal models *before* TDP-43 pathology is detectable\n- SNAP29 haploinsufficiency in zebrafish causes developmental defects, not progressive motor neuron degeneration\n- STX17 knockdown phenotypes in non-neuronal cells may not translate to mature neurons with distinct fusion machinery\n- Early-stage ALS shows *increased* autophagosomes—this is more consistent with initiation defects than fusion blocks\n\n### Falsifying Experiments\n1. Isolate autophagosomes and lysosomes from ALS patient spinal cord tissue; measure physical fusion competency directly via in vitro assays\n2. Use TDP-43 aggregate breakers; if SNAP29/STX17 availability normalizes before motor neuron function improves, TDP-43 is upstream\n3. Test whether syntaxin-17 is mislocalized in pre-symptomatic ALS models\n4. Knock down SNAP29 or STX17 in wild-type motor neurons; if this accelerates ALS phenotypes, support strengthens\n\n**Revised Confidence: 0.52**\n\n---\n\n## Hypothesis 4: VCP/Proteasome-Autophagy Crosstalk\n\n### Weak Links\n- **VCP has pleiotropic functions**: Regulates ER-associated degradation, nuclear envelope repair, and DNA damage response—autophagy is",
      "tokens_used": "1310",
      "persona_id": "persona-skeptic"
    }